Vyriad

is a Minnesota-based biotechnology company that develops and commercializes oncolytic virus therapies for the treatment of cancer...
Read more
Vyriad President & CEO: Stephen J. Russell

President & CEO

Stephen J. Russell

CEO Approval Rating

90/100

Est. Annual Revenue
$100K-5.0M
Agree?
Est. Employees
25-100
Agree?
Funding
$54.4M

Vyriad Competitors

1UroGen
2Dynavax
3Bexion Pharmaceuticals
4Oncorus
5TILT Biotherapeutics
6Genelux
7DNAtrix

Trending Companies